Cannabis and Hemp Industry Investment News
The patent includes claims for improved oral delivery of cannabinoids, nicotine, non-steroidal anti-inflammatory drugs and vitamins to treat a range o...
Canntab also closed a $300,000 deal with Pharmagenerics Solutions to purchase cannabis-processing equipment Canntab is focused on the manufacturing a...
After 20 minutes, 83% of participants noticed improvement, the company said, which jumped to 95% after an hour Innocan's pain relief formulation conta...
CEO Iris Bincovich said the SHIR Beauty & Science skincare brand combines the benefits of CBD into an innovative formula for fast-acting results T...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires () updated investors on the company's swift progress sin...
Developing revolutionary injectable CBD delivery system Strategic partnership with Hebrew University to study Liposome Platform Technology Tie-up with...
The drug delivery specialist said Altria now has non-exclusive license rights to use its DehydraTECH technology for both the US and worldwide markets ...
A study on mice using Innocan's technology showed a “prolonged release” of CBD in the blood for “at least three weeks after one administration” Innoca...
Lexaria Bioscience (CSE: LXX-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has received ethics board approval...
EXM called its inclusion in the body “timely” as the Portuguese government designated the broader health sciences industry to be one of national strat...
Now that the company has the blessing of its ethics board, it will begin the process of filing for approval from federal regulators Lexaria also annou...
Lexaria also has received verbal requests from existing licensees to prepare its facilities to produce at least 56 million servings during the calenda...
The new patent protects the use of Lexaria's DehydraTECH technology together with cannabinoids, nicotine and nonsteroidal anti-inflammatory drugs Lexa...
Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CEO Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has secured prote...
The new patented tablets consist of both Instant Release and Extended Release formulations with THC and CBD as well as a variety of terpenes and other...
Boldt Runners' Cannadips CBD is the leading CBD oral pouch brand in America, and Lexaria's fast-acting absorption technology is inside every tin Boldt...
Results indicated significant hydration increases for each two-, four-, eight, and 24-hour period after application The SHIR facial serum contains 300...
Inc's () Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development. Summers explains that the company ...
The company's consortium in Portugal will use the funds to study and develop disinfectants to combat SARScoV-2, the virus that causes coronavirus (COV...
What are you searching for? viewInnoCan Pharma Analyst Toby Ma highlighted the Israeli company’s potential clinical, licensing and commercial catalyst...
